Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kessler, F. K.
Right arrow Articles by Ritter, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kessler, F. K.
Right arrow Articles by Ritter, J. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol 18, 107-114, Copyright © 1997 by Oxford University Press


ARTICLES

Induction of a rat liver benzo[a]pyrene-trans-7,8-dihydrodiol glucuronidating activity by oltipraz and beta-naphthoflavone

FK Kessler and JK Ritter
Department of Pharmacology and Toxicology, School of Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298, USA.

We report here that rats possess a hitherto unrecognized xenobiotic- inducible hepatic 7,8-dihydro-7,8-diol-benzo[a]pyrene (BPD) UDP- glucuronosyltransferase (UGT) activity. BPD UGT activity is induced in female F344 rat liver by treatment with the selective Phase 2 conjugation enzyme inducer oltipraz [4-methyl-5-(2-pyrazinyl)-1,2- dithiole-3-thione at 75-450 mg/kg per day for 3 days] and also by a polycyclic aromatic hydrocarbon-type inducer, beta-naphthoflavone (80 mg/kg per day for 3 days). Incubations of oltipraz-treated rat liver microsomes with racemic trans BPD (100 microM) resulted in formation of two fluorescent glucuronides that were resolved by silica thin layer chromatography (Rf 0.5 and 0.6). Incubations with either the (-) or (+) trans BPD isomers resulted in selective formation of the Rf 0.5 [designated -DS, for (-) diol specific] or Rf 0.6 [designated +DS, for (+) diol specific] glucuronide, respectively. The -DS and +DS BPD glucuronides were fluorescent under long wave ultraviolet irradiation, dependent on the presence of UDP-glucuronic acid in the incubation, and were beta-glucuronidase-sensitive. The inducing effect of oltipraz on BPD UGT activity was dose-dependent. The mean BPD UGT activity of the vehicle-treated control group was 0.05 +/- 0.02 nmol/mg per min compared with 0.53 +/- 0.07 nmol/mg per min in the group treated with oltipraz (450 mg/kg per day for 3 days) (P < 0.001). The apparent Km of the induced BPD UGT for BPD was 20 microM, suggesting that the enzyme has the capacity to bind and turnover BPD under physiological conditions. Pretreatment with beta-naphthoflavone, but not phenobarbital, induced BPD UGT activity to approximately the same extent as oltipraz. Neither oltipraz nor beta-naphthoflavone exhibited induction of BPD UGT in livers of homozygous Gunn rats, which lack functional UGT1-encoded isozymes. We conclude that the oltipraz- and polycyclic hydrocarbonresponsive BPD UGT is a member of the UGT1 family. The role of this isoform as a modifier of susceptibility to carcinogenesis elicited by B[a]P remains to be determined.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
M. K. Shelby and C. D. Klaassen
Induction of Rat UDP-Glucuronosyltransferases in Liver and Duodenum by Microsomal Enzyme Inducers That Activate Various Transcriptional Pathways
Drug Metab. Dispos., October 1, 2006; 34(10): 1772 - 1778.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
K. K. Miles, F. K. Kessler, P. C. Smith, and J. K. Ritter
Characterization of Rat Intestinal Microsomal UDP-Glucuronosyltransferase Activity toward Mycophenolic Acid
Drug Metab. Dispos., September 1, 2006; 34(9): 1632 - 1639.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. K. Miles, F. K. Kessler, L. J. Webb, P. C. Smith, and J. K. Ritter
Adenovirus-Mediated Gene Therapy to Restore Expression and Functionality of Multiple UDP-Glucuronosyltransferase 1A Enzymes in Gunn Rat Liver
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1240 - 1247.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
K. K. Miles, S. T. Stern, P. C. Smith, F. K. Kessler, S. Ali, and J. K. Ritter
AN INVESTIGATION OF HUMAN AND RAT LIVER MICROSOMAL MYCOPHENOLIC ACID GLUCURONIDATION: EVIDENCE FOR A PRINCIPAL ROLE OF UGT1A ENZYMES AND SPECIES DIFFERENCES IN UGT1A SPECIFICITY
Drug Metab. Dispos., October 1, 2005; 33(10): 1513 - 1520.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
P. G. Wells, P. I. Mackenzie, J. Roy Chowdhury, C. Guillemette, P. A. Gregory, Y. Ishii, A. J. Hansen, F. K. Kessler, P. M. Kim, N. Roy Chowdhury, et al.
GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE
Drug Metab. Dispos., March 1, 2004; 32(3): 281 - 290.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. J. Auyeung, F. K. Kessler, and J. K. Ritter
Mechanism of Rat UDP-Glucuronosyltransferase 1A6 Induction by Oltipraz: Evidence for a Contribution of the Aryl Hydrocarbon Receptor Pathway
Mol. Pharmacol., January 1, 2003; 63(1): 119 - 127.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
F. K. Kessler, M. R. Kessler, D. J. Auyeung, and J. K. Ritter
Glucuronidation of Acetaminophen Catalyzed by Multiple Rat Phenol UDP-Glucuronosyltransferases
Drug Metab. Dispos., March 1, 2002; 30(3): 324 - 330.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. G. Lamb and M. R. Franklin
Early Events in the Induction of Rat Hepatic UDP-Glucuronosyltransferases, Glutathione S-Transferase, and Microsomal Epoxide Hydrolase by 1,7-Phenanthroline: Comparison with Oltipraz, tert-Butyl-4-hydroxyanisole, and tert-Butylhydroquinone
Drug Metab. Dispos., September 1, 2000; 28(9): 1018 - 1023.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
Q. Li, G. Lamb, and R. H. Tukey
Characterization of the UDP-Glucuronosyltransferase 1A Locus in Lagomorphs: Evidence for Duplication of the UGT1A6 Gene
Mol. Pharmacol., July 1, 2000; 58(1): 89 - 97.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. P. Metz and J. K. Ritter
Transcriptional Activation of the UDP-Glucuronosyltransferase 1A7 Gene in Rat Liver by Aryl Hydrocarbon Receptor Ligands and Oltipraz
J. Biol. Chem., March 6, 1998; 273(10): 5607 - 5614.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. Vargas, J. G. Lamb, and M. R. Franklin
Phase II-Selective Induction of Hepatic Drug-Metabolizing Enzymes by Oltipraz [5-(2-Pyrazinyl)-4-methyl-1,2-dithiol-3-thione], 1,7-Phenanthroline, and 2,2'-Dipyridyl in Rats Is Not Accompanied by Induction of Intestinal Enzymes
Drug Metab. Dispos., February 1, 1998; 26(2): 91 - 97.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
I. Jaitovitch-Groisman, N. Fotouhi-Ardakani, R. L. Schecter, A. Woo, M. A. Alaoui-Jamali, and G. Batist
Modulation of Glutathione S-Transferase Alpha by Hepatitis B Virus and the Chemopreventive Drug Oltipraz
J. Biol. Chem., October 20, 2000; 275(43): 33395 - 33403.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.